Arimidex Therapy compliance Electronic Monitoring System - ARTEMIS

Study identifier:D5390L00076

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

ARimidex Therapy compliance Electronic MonitorIng System. A study to evaluate the impact of educational material on the adherence to treatment with adjuvant anastrozole for postmenopausal women with hormone sensitive early breast cancer

Medical condition

Breast Cancer

Phase

-

Healthy volunteers

No

Study drug

Anastrozole

Sex

Female

Actual Enrollment

104

Study type

Observational

Age

N/A

Date

Study Start Date: 01 Jun 2009
Primary Completion Date: 01 Dec 2009
Study Completion Date: 01 Dec 2010

Study design

Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Nov 2013 by AstraZeneca Pharmaceuticals

Sponsors

AstraZeneca Pharmaceuticals

Collaborators

Aardex Pharmionic

Inclusion and exclusion criteria